𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fetal nuchal translucency and prenatal diagnosis of β-thalassaemia

✍ Scribed by Giovanni Monni; Rosa M. Ibba; Maria A. Zoppi; Monica Putzolu; Marcella Floris; Antonio Cao

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
134 KB
Volume
19
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.

✦ Synopsis

In Sardinia, fetal karyotyping for couples at risk for -thalassaemia is offered only to women _35 years and for specific risk of chromosomopathies. This policy is not easily accepted by the couples who insistently request additional karyotyping. In order to select those at highest risk of chromosomal abnormalities among young women, fetal nuchal translucency (NT) thickness measurement was performed in 510 fetuses to assess the chromosomal risk before chorionic villus sampling. A risk _1/100 was judged positive and worthy of additional karyotyping. 126 cases interrupted the pregnancy after a result of homozygous -thalassaemia, hence 384 pregnancies were included in the study. 22 (5.7 per cent) fetuses were found NT positive. A total of three chromosomal abnormalities were detected. The NT test was positive in all three cases of chromosomopathies detected (100 per cent) and in 19 of 381 (4.98 per cent) normal karyotype fetuses. No features of major chromosomal abnormalities were reported among the newborns whose NT had resulted normal. These preliminary results have confirmed the efficacy of NT testing to assess the risk of trisomy 21 and other chromosomopathies and enhanced its utility in pregnancies already suited to sampling in the first-trimester for Mendelian disorders.

📜 SIMILAR VOLUMES

Prenatal diagnosis of β-thalassaemia and
Prenatal diagnosis of β-thalassaemia and other haemoglobinopathies in India
✍ Chitra Thakur (Mahadik); Flavian Vaz; Monisha Banerjee; Chhaya Kapadia; P. G. Na 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

This paper reports prenatal diagnosis of 787 fetuses of b-thalassaemia and other haemoglobinopathies in Indian high-risk communities. DNA based diagnosis was offered in the ®rst, as well as the second trimester, in 489 pregnancies (with ®ve twins) on fetal tissues such as chorionic villus (CV) and a

Increased nuchal translucency thickness
Increased nuchal translucency thickness in a fetus at risk for β-thalassaemia
✍ George Makrydimas; Ioannis Georgiou; Maria Syrrou; Chariclia Skendou; Dimitrios 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

In Greece and other Mediterranean countries up to 10% of the population are carriers of beta-thalassaemia and this is the most common indication for chorion villus sampling (CVS): Cytogenetic analysis of the samples is not carried out routinely, but is confined only to women aged 35 years or more. I

Prenatal diagnosis of β-thalassaemia by
Prenatal diagnosis of β-thalassaemia by reverse dot-blot hybridization
✍ Pranee Winichagoon; Vannarat Saechan; Roongrat Sripanich; Chamnong Nopparatana; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Thalassaemia is the most common genetic disease and is a public health problem of Thailand. Prevention and control of -thalassaemia diseases need accurate diagnosis of carriers and proper genetic counselling. Prenatal diagnosis is needed to prevent birth of the thalassaemic offspring in the couple a

Prenatal diagnosis of β-thalassaemia: ex
Prenatal diagnosis of β-thalassaemia: experience in a developing country
✍ Renu Saxena; Pawan K. Jain; Elizabeth Thomas; Ishwar C. Verma 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

We present our experience with the amplification refractory mutation system (ARMS) for the prenatal diagnosis of -thalassaemia in 415 pregnancies of 360 women. Five mutations of the -thalassaemia gene common in Asian Indians accounted for 89•2 per cent and rare mutations for 7•2 per cent of all muta

Evaluation of first-trimester screening
Evaluation of first-trimester screening by fetal nuchal translucency and maternal age
✍ P. Theodoropoulos; D. Lolis; C. Papageorgiou; S. Papaioannou; N. Plachouras; G. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

The aim of this screening study was to evaluate first-trimester screening for chromosomal defects by fetal nuchal translucency thickness at 10-14 weeks of gestation in four Fetal Medicine Units in Greece. Estimates of the risk for trisomy 21 were calculated taking into account fetal nuchal transluce